- 1
- L.G. Strauss, P.S. Conti The application of PET in clinical oncology J Nucl Med 32, 623-648 (1991).
- 2
- A.Giorgetti, D.Volterrani. Applicazioni della Tomografia ad Emissione di Positroni (PET) con [Fluoro-18]-fluoro-2-desossi-D-glucosio
nella pratica clinica oncologica Radiol Med 103: 293-318, (2002)
- 3
- O. Warburg. The Metabolism of Tumors. New York,NY, Smith RR, (1931).
- 4
- Som P, Atkins HL, Bandoypahyay D. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic
tracer for rapid tumor dection. J. Nucl. Med. 21: 670-675; (1980).
- 5
- Costa DC, Visvikis D, Crosdale I. Positron emission and computed X-ray tomography: a coming together. Nuc Med
Commun 24: 351-358, (2003).
- 6
- Townsend DW, Beyer T. A combined PET/CT scanner: the path to true image fusion. Br J Radiol 75: S24-S30, (2002).
- 7
- Czernin Y.PET/CT: Imaging function and structure. J Nucl Med 45 (suppl):1S-103S, (2004).
- 8
- Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET-CT scanner. Med Phys. ;25:2046-2053.(1998)
- 9
- R.E. Coleman, R.D. Tesar, A Perspective on clinical PET imaging, Clinical Positron Imaging, Volume 2, Number 6.
- 10
- W.Sureshbabu, O. Mawlawi. PET-CT Imaging Artifacts, J Nucl Med Technol; 33:156-161(2005)
- 11
- Gopal B.Saha - Basics of PET imaging: physics, chemistry and regulations. Springer 2005
- 12
- http://marr.bsee.swin.edu.au/lectures/het408/ radio.pdf
- 13
- www.aimn.it/ecm/pisa_01/Gilardi.pdf
- 14
- Diapositive dal corso del prof.M.Schwarz
Carlo
2008-03-02